A pharmaceutical scientist is developing a novel

antimicrobial agent intended for systemic use against a wide range of bacterial

pathogens. To be clinically successful, the compound must selectively target

bacteria while remaining safe for human tissues and be able to access

intracellular and periplasmic bacterial components.

A medical trainee is reviewing why certain antibiotics fail

despite being effective against typical Gram‑positive organisms. Vancomycin is

known to inhibit cell wall synthesis in many Gram‑positive bacteria, yet it shows

little activity against

Clinical studies of severe COVID‑19 have

highlighted dysregulated host immune responses that contribute significantly to

lung pathology. When COVID-19 causes a severe infection, it is common for

immune pathways to show dysregulation.

Influenza virus entry into host cells depends on coordinated

structural changes in the haemagglutinin (HA) protein following attachment to

the cell surface. Successful infection requires both receptor engagement and

fusion of the viral envelope with the host cell membrane.

A microbiology laboratory isolates a bacterial pathogen that

is resistant to a ribosome‑targeting antimicrobial agent.

Further analysis shows the resistance is due to a bacterial enzyme that

inactivates the drug through covalent modification, which adds a phosphate,

preventing it from interacting with the ribosomal subunit. The affected drug is

water‑soluble

and depends on active transport systems to cross the bacterial cell envelope.

Which category of antibiotics most commonly exhibits this

type of resistance mechanism?

Tumour necrosis factor (TNF) plays a central role in chronic

inflammatory diseases, and TNF inhibitors rapidly reduce tissue inflammation

and clinical symptoms. Notably, TNF blockade often improves disease outcomes

without eliminating autoreactive lymphocytes or autoantibody production,

suggesting that TNF acts upstream of multiple inflammatory processes rather

than directly determining antigen specificity.

Which TNF‑mediated process most directly

explains its key role in sustaining autoimmune pathology?

Affinity maturation and class switch recombination require

targeted DNA lesions within immunoglobulin loci. AID initiates these processes

by deaminating cytidine residues in single-stranded DNA during transcription. A

mutation abolishes the ability of AID to modify cytidines, while leaving

transcription and DNA repair pathways intact.

Germinal centre (GC) B cells undergo rapid proliferation,

somatic hypermutation, and selection while delaying terminal differentiation

and apoptosis. BCL6 is highly expressed in GC B cells and functions as a transcriptional

repressor of genes involved in DNA damage responses, cell-cycle arrest, and

plasma cell differentiation. In experimental systems where BCL6 is selectively

deleted in B cells, germinal centres fail to form and antibody affinity

maturation is severely impaired.

A clinician evaluates a patient with immune-mediated

inflammation affecting kidney glomeruli, synovial joints, and cutaneous tissue

simultaneously. Serological testing reveals autoantibodies against ubiquitously

expressed self-antigens.

Which feature most strongly justifies classification of this

condition as a systemic autoimmune disorder?

Long‑lived plasma cells can persist for

years in specialised bone marrow niches, continuing to secrete high‑affinity

antibodies even in the absence of ongoing antigen exposure. Experimental

disruption of stromal cell interactions or cytokines such as APRIL, BAFF and IL‑6

leads to a rapid loss of these plasma cells.